what are the implications of kras mutations in colon cancer?
Published 11 months ago • 167 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
0:30
kras in the setting of colon cancer
-
13:45
understanding the mutations behind colorectal cancer | dr kate marks
-
47:45
resistance in braf and kras mutant cancers - by ryan corcoran, md, phd
-
0:47
highlighting the benefits of kras testing in colorectal cancer
-
7:57
case 3: kras-mutated metastatic colon cancer
-
22:49
biomarkers for treatment selection in colon cancer
-
6:21
braf and ras mutation status in colorectal cancer
-
4:03
unraveling the genetics of cancer: why some families are more at risk
-
3:46
targeting colorectal cancer: kras and nras mutations
-
2:01
clarifying the mechanism of egfr inhibition in kras g13d colorectal cancer
-
0:42
richard m. goldberg, md, fasco on kras wild type or mutant in right or left-sided mcrc patients
-
0:35
data on kras inhibitors in lung cancer at wclc 2022
-
1:43
survival differences in kras/braf mutations in mcrc
-
1:25
challenges of kras-targeting for lung cancer therapy
-
4:46
we're finally beginning to crack the kras nut in colorectal cancer
-
7:36
emccc 2010: the use of panitumumab to treat colorectal cancer
-
3:26
implications of ras mutational status in subsets of patients with newly diagnosed aml
-
22:10
novel agents and targets in colorectal cancer
-
2:39
onvansertib for second-line treatment of kras-mutated mcrc